NEW DELHI: Shares in Lupin Ltd slump nearly 5 per cent following the launch of rival Mylan Inc's generic version of the cholesterol-lowering Tricor... ...

Pharma firms stare at setbacks in the new regime. Consumers may celebrate the new drug price control order (DPCO), which was unveiled Thursday, as... ...

In an affirmative sign, Ranbaxy shrugged off early losses after Monday's ruling to steadily climb 1.75 percent to Rs 463.45 on Wednesday on the... ...

MUMBAI: The damage to India's largest drug major, Ranbaxy , translates well beyond the $500 million — which was confirmed as total penalty on May... ...

lost 2.6 per cent on the bourses, closing at Rs 2,026.30 after the company's March quarter numbers, especially on the margins front, were lower... ...

1. daiichi sankyo
2. glenmark
3. fda
4. dr reddy
5. united states
6. fy12
7. dpc hospital
8. central broking
9. divi
10. ebitda
11. api
12. dhawan
13. japan
14. pat
15. lupin
16. rediff realtime news
17. ranbaxy''s asia pacific
18. clsa
19. emkay global
20. kyowa
21. hemant bakhru
22. cipla
23. sun pharma
24. ranbaxy
25. hdfc securities
26. israeli
27. taro pharma
28. dusa & rsquo
29. drug controller general of india & rsquo
30. us food and drug administration & rsquo

Top Coverage News